LYC-002

N/A

Report date: 2024/06/17 17:30:57

Base Information

Drug NameLYC-002
Drug Alias NameLYC002
ClassificationBiologics > Protein drugs > Recombinant protein > Recombinant cytokines
Mechanisms of ActionColony stimulating factor 3 receptor agonists
TargetsColony stimulating factor 3 receptor
Therapy Area/IndicationsChemotherapy-Induced Febrile Neutropenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesBeijing Liangyuan Bioscience Llc
China Registration ClassN/A

Develop Information

Active CompaniesBeijing Liangyuan Bioscience Llc
Inactive CompaniesN/A
Active IndicationsChemotherapy-Induced Febrile Neutropenia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A